Presentation Information
[OE1-5]The impact of common germline risk on somatic alterations and clinical features across cancers
○Shinichi Namba1, Yuki Saito2,3, Yasunori Kogure2, Tatsuo Masuda1,4,5, Yukinori Okada1,6,7,8, Keisuke Kataoka2,9 (1.Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan, 2.Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan, 3.Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan, 4.Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan, 5.StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Osaka, Japan, 6.Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, 7.Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 8.Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan, 9.Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)